Working... Menu
Trial record 2 of 11 for:    QUADRA

A Study of Niraparib in Patients With Ovarian Cancer Who Have Received Three or Four Previous Chemotherapy Regimens (QUADRA)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02354586
Recruitment Status : Active, not recruiting
First Posted : February 3, 2015
Last Update Posted : May 17, 2019
Facing Our Risk of Cancer Empowered
Myriad Genetics, Inc.
Information provided by (Responsible Party):
Tesaro, Inc.

No Study Results Posted on for this Study
  Recruitment Status : Active, not recruiting
  Actual Primary Completion Date : February 28, 2018
  Estimated Study Completion Date : December 2019
  Certification/Extension First Submitted : May 13, 2019